Spirosure is based in Pleasanton, California focusing on research, development and commercialization of novel breath analysis devices for application in disease diagnosis and management.

Our mission is to provide cost effective, non-invasive products for the management of chronic pulmonary diseases such as Asthma, COPD, Cystic Fibrosis and Pulmonary Hypertension.

Through the use of new sensors, proprietary algorithms and consumer technology we aim to improve health outcomes through preventive healthcare.

OVERVIEW

Founded – 2011
Headquarters – Pleasanton, CA
President and CEO – Dean Zikria
Founders – Solomon Ssenyange, Ryan Leard

INVESTORS

Shanghai Fosun Pharmaceutical
NTK Technologies
Iconical
South Valley Angels
Europlay Capital Advisors
Carmen Innovations
Ohio Innovation Fund

KEY ADVISORS

Eric Topol, MD
Prabir K. Dutta, PhD

SCIENTIFIC ADVISORY BOARD

Randall W. Brown, MD
Bradley Chipps, MD
Michael Marcus, MD
Maeve O'Conner, MD
Stuart W. Stoloff, MD
James Wolfe, MD